US 7217808
RFRP-3 and DNA thereof
granted A61KA61K38/00
Quick answer
US patent 7217808 (RFRP-3 and DNA thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/00